Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 13 | 7↓44.4% | 2↓69.2% | 2↓17.9% | 0↓88.9% |
| Gross Profit | -61 | 4↑107.3% | -108↓2533.9% | 1↑100.6% | -2↓442.4% |
| Operating Income | -67 | -77↓13.5% | -129↓68.6% | -219↓69.8% | -331↓51.2% |
| Net Income | -76 | -82↓8.1% | -145↓77.6% | -241↓66.2% | 1,688↑799.2% |
| EBITDA | -64 | -75↓18.1% | -126↓66.9% | -207↓64.3% | 1,703↑924.1% |
| EPS Diluted | -2.99 | -2.15↑28.1% | -3.62↓68.4% | -5.12↓41.4% | 116.58↑2377.0% |